IP Library Granted Patent US 10,246,741
Granted Patent B2
US 10,246,741 · App. 14/122,573 · Granted Apr 2, 2019

Coupling method

Inventors: James Clarke (Oxford, GB); James White (Oxford, GB); John Milton (Oxford, GB); Clive Brown (Cambridge, GB)
Assignee: Oxford Nanopore Technologies Ltd.
C12Q1/6869B82Y15/00G01N27/44743G01N33/48721
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,246,741
App. No.
14/122,573
Granted
Apr 2, 2019
Kind
B2
Abstract

The invention relates to a new method of determining the presence, absence or characteristics of an analyte. The analyte is coupled to a membrane. The invention also relates to nucleic acid sequencing.

Claims (33)

1. A method for detecting polynucleotides, comprising:

(a) providing a membrane in which is present a nanopore that provides a channel through the membrane;

(b) contacting the membrane, in an ionic solution, with polynucleotides, wherein following contact with the membrane the polynucleotides are tethered to the membrane via a tethering group;

(c) applying a potential difference across the membrane and detecting a first polynucleotide using the nanopore, from among the polynucleotides tethered to the membrane; and

(d) detecting a second polynucleotide, from among the polynucleotides tethered to the membrane, using the same nanopore, wherein the second polynucleotide is not the first polynucleotide.

2. The method according to claim 1 , wherein the membrane is an amphiphilic layer or a solid state layer.

3. The method according to claim 1 , wherein the membrane is a lipid bilayer.

4. The method according to claim 1 , wherein the tethering group comprises a hydrophobic anchor.

5. The method according to claim 4 , wherein the hydrophobic anchor is a lipid, fatty acid, sterol, carbon nanotube or amino acid.

6. The method according to claim 4 , wherein the hydrophobic anchor is capable of embedding in the membrane.

7. The method according to claim 1 , wherein the tethering group comprises a linker.

8. The method according to claim 7 , wherein the linker comprises a polynucleotide, polyethylene glycol, polysaccharide, or polypeptide.

9. The method according to claim 1 , wherein the polynucleotide is tethered transiently to the membrane.

10. The method according to claim 1 , wherein the first polynucleotide and the second polynucleotide are detected based on ion flow through the nanopore that is measured via an electrical means.

11. The method according to claim 1 , wherein the nanopore is a protein nanopore.

12. The method according to claim 11 , wherein the protein nanopore is derived from Msp or α-hemolysin (α-HL).

13. The method according to claim 1 , wherein the nanopore comprises a molecular adaptor that mediates interaction of the polynucleotide with the nanopore.

14. The method according to claim 1 , wherein the nanopore is coupled to a polynucleotide binding protein, which is optionally an exonuclease or a polymerase.

15. The method according to claim 1 , wherein the first polynucleotide and the second polynucleotide are detected based on ion flow through the nanopore that is measured by measuring a current passing through the nanopore.

16. The method according to claim 1 , wherein the polynucleotide comprises a target polynucleotide.

17. The method according to claim 16 , wherein the method comprises digesting a target polynucleotide to provide a fragment and the fragment sequence is determined.

18. The method according to claim 1 , wherein the tethering group comprises a polypeptide.

19. The method according to claim 1 , wherein the polynucleotide is present in the solution of (b) at a concentration of less than 0.01 pM.

20. The method according to claim 1 , wherein the polynucleotide is present in the solution of (b) at a concentration of less than 0.1 pM.

21. The method according to claim 1 , wherein the polynucleotide is present in the solution of (b) at a concentration of less than 1 pM.

22. The method according to claim 1 , wherein the polynucleotide is present in the solution of (b) at a concentration of less than 10 pM.

23. The method according to claim 1 , wherein the polynucleotide is present in the solution of (b) at a concentration of less than 100 pM.

24. The method according to claim 1 , wherein the polynucleotide is present in the solution of (b) at a concentration of about 0.001 pM to about 1 nM.

25. The method according to claim 1 , wherein rate of interaction of the molecules of the polynucleotide with the nanopore is increased as compared to rate of interaction of molecules of the polynucleotide with the nanopore in the absence of the tethering group.

26. The method according to claim 25 , wherein the rate of interaction of the molecules of the polynucleotide is increased by at least three orders of magnitude.

27. The method according to claim 1 , wherein the effective concentration of the polynucleotide at the nanopore is increased as compared to the concentration of the polynucleotide in the solution of (b).

28. The method according to claim 1 , wherein a single nanopore providing an ion channel through the membrane is present in the membrane.

29. The method according to claim 1 , wherein the polynucleotide is functionalized with the tethering group.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2014
From: CLARKE, JAMES; WHITE, JAMES; MILTON, JOHN; BROWN, CLIVE
To: OXFORD NANOPORE TECHNOLOGIES LIMITED
Reel/Frame 032620/0306 →
Continuity (3)
Provisional Application 61490860 · May 27, 2011
Provisional Application 61599246 · Feb 15, 2012
Related Publication 20140262784A1 · Sep 18, 2014
Cited By (7)
US 12,372,511 US 12,398,421 US 12,473,595 US 12,509,721 US 12,571,035 US 12,584,170 US 12,704,516